Isorhamnetin Attenuates Hyperglycemia-Induced Diabetic Nephropathy-Like Alterations in Human Embryonic Kidney Cells (HEK-293): In vitro Insights into the Potential Role of FOXO1
Indian Journal of Pharmaceutical Education and Research · 23.10.2026 · 61 (1) · 200-211
DOI: 10.5530/ijper.20274613 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Pharmaceutical Education and Research, online erschienen am 23.10.2026. Verfasst von Lin Zhang und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Zhang, L., Zhou, M., Albaqami, A., Oraibi, O., Somaili, M., & Mireani, M. (2026). Isorhamnetin Attenuates Hyperglycemia-Induced Diabetic Nephropathy-Like Alterations in Human Embryonic Kidney Cells (HEK-293): In vitro Insights into the Potential Role of FOXO1. Indian Journal of Pharmaceutical Education and Research, 61(1), 200-211. https://doi.org/10.5530/ijper.20274613
Vancouver
Zhang L, Zhou M, Albaqami A, Oraibi O, Somaili M, Mireani M. Isorhamnetin Attenuates Hyperglycemia-Induced Diabetic Nephropathy-Like Alterations in Human Embryonic Kidney Cells (HEK-293): In vitro Insights into the Potential Role of FOXO1. Indian Journal of Pharmaceutical Education and Research. 2026;61(1):200-211. doi:10.5530/ijper.20274613
BibTeX
@article{Zhang2026,
author = {Zhang, Lin and Zhou, Meilan and Albaqami, Amirah and Oraibi, Omar and Somaili, Mohammed and Mireani, May},
title = {Isorhamnetin Attenuates Hyperglycemia-Induced Diabetic Nephropathy-Like Alterations in Human Embryonic Kidney Cells (HEK-293): In vitro Insights into the Potential Role of FOXO1},
journal = {Indian Journal of Pharmaceutical Education and Research},
year = {2026},
volume = {61},
number = {1},
pages = {200--211},
doi = {10.5530/ijper.20274613}
}
EUVIMED